Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling
By: S. Kalra, A. H. Aamir, M. F. Amin, S. Bajaj, U. Bulugahapitiya, A. K. Das, S. Ghosh, S. Gunatilake, S. A. Mahar, N. Qureshi, S. A. Raza, D. Shrestha, N. Somasundaram, M. Sumanatilleke and A. Wijesinghe
Open Access
|Aug 2016DOI: https://doi.org/10.4038/sjdem.v6i2.7316 | Journal eISSN: 2012-998X
Language: English
Page range: 55 - 57
Published on: Aug 29, 2016
Published by: Sri Lanka College of Endocrinologists
In partnership with: Paradigm Publishing Services
© 2016 S. Kalra, A. H. Aamir, M. F. Amin, S. Bajaj, U. Bulugahapitiya, A. K. Das, S. Ghosh, S. Gunatilake, S. A. Mahar, N. Qureshi, S. A. Raza, D. Shrestha, N. Somasundaram, M. Sumanatilleke, A. Wijesinghe, published by Sri Lanka College of Endocrinologists
This work is licensed under the Creative Commons License.